PeptideDB

CDK2-IN-31

CAS: 2813260-27-2 F: C37H52N6O5 W: 660.85

CDK2-IN-31 (compound I-125A) is a CDK2 inhibitor. CDK2-IN-31 can be used in cancer research.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity CDK2-IN-31 (compound I-125A) is a CDK2 inhibitor. CDK2-IN-31 can be used in cancer research[1].
CAS 2813260-27-2
Formula C37H52N6O5
Molar Mass 660.85
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Yuanjin Zhang, et al. An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes. Nat Chem Biol. 2024 Sep 18. [2]. Zhang Y, et al. An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes. Nat Chem Biol. 2024 Sep 18.